Polymorphic form of montelukast sodium

Details for Australian Patent Application No. 2004229507 (hide)

Owner Merck & Co., Inc. Merck Frosst Canada Ltd.

Inventors Gentzler, Michael B.; Clas, SophieDorothee; Bazin, Cynthia; Dalton, Chad; Michaels, James N.; Wu, Michael Guojie; Chou, Jun-Hong

Agent Spruson & Ferguson

Pub. Number AU-B-2004229507

PCT Pub. Number WO2004/091618

Priority 60/462,941 15.04.03 US

Filing date 12 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 18 December 2008

International Classifications

A61K 31/47 (2006.01) - Quinolines

C07D 215/18 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/091618 Priority application(s): WO2004/091618

18 December 2008 Application Accepted

  Published as AU-B-2004229507

23 April 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the co-patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229512-Aerosolization apparatus with capsule puncture alignment guide

2004229503-Method, system and algorithm related to treatment planning for vision correction